4 studies found for:    b7-dc
Show Display Options
Rank Status Study
1 Active, not recruiting Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: B7-DC cross-linking antibody rHIgM12B7;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis
2 Active, not recruiting AMP-224, a PD-1 Inhibitor, in Combination With Stereotactic Body Radiation Therapy in People With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer;   Colorectal Neoplasms;   Colorectal Carcinoma
Interventions: Drug: AMP-224;   Radiation: Stereotactic Body Radiation Therapy(SBRT);   Drug: Cyclophosphamide
3 Completed Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: BMS-936559;   Drug: Placebo for BMS-936559
4 Recruiting A Study Evaluating the Effect of Pembrolizumab (MK-3475) in Participants With Renal Cell Cancer (MK-3475-031)
Condition: Renal Cell Cancer
Interventions: Drug: Pembrolizumab;   Procedure: Surgical Resection

Indicates status has not been verified in more than two years